- Home
- EQX vs WGS Comparison
EQX vs WGS Comparison
Compare EQX & WGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQX
- WGS
- Stock Information
- Founded
- EQX 2007
- WGS 2017
- Country
- EQX Canada
- WGS United States
- Employees
- EQX N/A
- WGS N/A
- Industry
- EQX Precious Metals
- WGS Retail: Computer Software & Peripheral Equipment
- Sector
- EQX Basic Materials
- WGS Technology
- Exchange
- EQX Nasdaq
- WGS Nasdaq
- Market Cap
- EQX 2.3B
- WGS 2.0B
- IPO Year
- EQX N/A
- WGS N/A
- Fundamental
- Price
- EQX $5.84
- WGS $69.48
- Analyst Decision
- EQX
- WGS Strong Buy
- Analyst Count
- EQX 0
- WGS 5
- Target Price
- EQX N/A
- WGS $80.60
- AVG Volume (30 Days)
- EQX 5.5M
- WGS 787.4K
- Earning Date
- EQX 02-21-2025
- WGS 02-18-2025
- Dividend Yield
- EQX N/A
- WGS N/A
- EPS Growth
- EQX 302.88
- WGS N/A
- EPS
- EQX 0.60
- WGS N/A
- Revenue
- EQX $1,236,929,000.00
- WGS $267,228,000.00
- Revenue This Year
- EQX $45.56
- WGS $43.70
- Revenue Next Year
- EQX $57.70
- WGS $17.28
- P/E Ratio
- EQX $10.88
- WGS N/A
- Revenue Growth
- EQX 17.84
- WGS 29.41
- 52 Week Low
- EQX $3.95
- WGS $2.85
- 52 Week High
- EQX $6.50
- WGS $98.87
- Technical
- Relative Strength Index (RSI)
- EQX 56.46
- WGS 40.28
- Support Level
- EQX $5.79
- WGS $66.81
- Resistance Level
- EQX $6.15
- WGS $98.87
- Average True Range (ATR)
- EQX 0.21
- WGS 7.98
- MACD
- EQX 0.08
- WGS -2.10
- Stochastic Oscillator
- EQX 73.87
- WGS 8.33
About EQX Equinox Gold Corp.
Equinox Gold Corp is a mining company engaged in the operation, acquisition, exploration and development of mineral properties, with a focus on gold. Equinox Gold has around seven operating gold mines and a clear plan to increase production by advancing pipeline of growth projects.
About WGS GeneDx Holdings Corp.
GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.